Living With
Blepharospasm

When you have blepharospasm, the simplest everyday task can become a challenge. Blepharospasm causes muscles around the eyes to contract uncontrollably. This can make it difficult to read a book, drive a car, or do anything requiring your vision. Because of this, many people with blepharospasm feel like they have lost some of their independence.

But it’s important to know that, when it comes to treatment for blepharospasm, you have options. Talk to your doctor; together you can decide on the treatment that’s right for you.

patient_3.0_Bleph_definition

Types of Blepharospasm

  • Primary blepharospasm: no cause can be found through examination or diagnostic testing
  • Secondary blepharospasm: a cause is identified, which could include:
    • Exposure to a drug known to cause the condition
    • Another disorder of which blepharospasm is a symptom

     

Signs and Symptoms

People with blepharospasm experience some or all of the following symptoms1:

  • Excessive blinking
  • Light sensitivity
  • Dry eyes
  • Eye irritation
  • Watering eyes

Symptoms may get worse over time. Some people get temporary relief from eye closures by talking or lightly touching or rubbing the eyelids.1 But often, medication is needed to provide relief.

 

Discover XEOMIN® (incobotulinumtoxinA)

Xeomin is indicated to treat adult patients who have been or are being treated with Botox® (onabotulinumtoxinA) for blepharospasm. Be sure to discuss your previous dose, response, and any side effects you may have experienced to help your doctor determine your initial dose.2

Learn More about XEOMIN for blepharospasm.

Blepharospasm Patient Brochure
Download this patient brochure for more information on treatment of blepharospasm with XEOMIN.

Reference

  1. Tsui JKC. Blepharospasm and hemifacial spasm. In: Brin MF, Comella C, Jankovic J, eds. Dystonia: Etiology, Clinical Features, and Treatment. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:151-157.
  2. XEOMIN® [package insert]. Raleigh, NC: Merz North America, Inc; 2015.